-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Chloroquine (CQ) and hydroxychloroquine (HCQ) are in the aminoquinoline class
Effects of CQ and HCQ on activation of NLRP3 inflammasomes:
In one study, researchers investigated how chloroquine inhibited activation of the NLRP3 inflammasome and protected mice from endotoxin shock
Both artemisinin and hydroxychloroquine have anti-inflammatory and immunomodulatory activities
To study the effects of hydroxychloroquine on NLRP3 inflammatory bodies, serum amyloid A (SAA) was used to stimulate human neutrophils and the secretion
Other drugs that inhibit the NLRP3 inflammatory body:
CQ and HCQ were the most important and certainly the most challenging drugs in the treatment of COVID-19 in the study, but a range of drugs, including statins, antivirals, interferons, antiallergic compounds, and immunomodulators, are currently being used in clinical trials
Taken together, hundreds of clinical trials are being conducted in different countries to investigate potential treatments for
References: Bahadoram M, Keikhaei B, Saeedi-Boroujeni A, Mahmoudian-Sani MR.